trending Market Intelligence /marketintelligence/en/news-insights/trending/rdp8hr1zdldshyu8dlilug2 content esgSubNav
In This List

Scynexis launches common stock, warrants offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Scynexis launches common stock, warrants offering

Jersey City, N.J.-based drugmaker Scynexis Inc. is selling common shares and warrants in an underwritten public offering.

Guggenheim Securities LLC is serving as the sole book-running manager for the offer.

Scynexis develops drugs for treating infections.